Showing results (1-10 of 107) with videos related to
Sort By:
Pageof 11
Endocrinology and Metabolism (Seoul, Korea)|February 21, 2019
Mouse Models as a Tool for Understanding Progression in BrafV600E-Driven Thyroid CancersIñigo Landa, Jeffrey A KnaufEndocrine-Related Cancer|July 6, 2013
Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cellsMatti L Gild, Iñigo Landa, Mabel Ryder, et al.Current Opinion in Endocrine and Metabolic Research|August 14, 2023
InTERTwined: how TERT promoter mutations impact BRAFV600E-driven thyroid cancersIñigo LandaJournal of Molecular Endocrinology|May 26, 2011
Association studies in thyroid cancer susceptibility: are we on the right track?Iñigo Landa, Mercedes RobledoJournal of Molecular Endocrinology|August 11, 2011
Association studies in thyroid cancer susceptibility: are we on the right track?Iñigo Landa, Mercedes RobledoEndocrine Connections|December 11, 2023
The prognostic power of gene mutations in thyroid cancerSara Ahmadi, Iñigo LandaNature Reviews. Endocrinology|December 4, 2023
Genomic alterations in thyroid cancer: biological and clinical insightsIñigo Landa, Maria E CabanillasEndocrinology|July 28, 2023
Mechanistic Insights of Thyroid Cancer ProgressionLuis Javier Leandro-García, Iñigo LandaBiorxiv : the Preprint Server for Biology|February 7, 2023
Telomerase reactivation induces progression of mouse Braf V600E -driven thyroid cancers without telomere lengtheningIñigo Landa, Caitlin Em Thornton, Bin Xu, et al.Pageof 11